Related Experiment Video
Updated: Jul 17, 2026
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Translational research in inflammatory bowel disease.
Maria T Abreu1, Miles P Sparrow
1Inflammatory Bowel Disease Center, Mount Sinai School of Medicine, 1 East 100th Street, Box 1069, New York, NY 10029, USA. maria.abreu@mssm.edu
The Mount Sinai Journal of Medicine, New York
|February 8, 2007
Summary
Idiopathic inflammatory bowel diseases (IBDs), like Crohn's disease and ulcerative colitis, stem from immune system dysfunction in genetically susceptible individuals. Recent research highlights the roles of NOD2 gene, toll-like receptors, and cytokines in IBD development and patient care.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
- Genetics
Background:
- Idiopathic inflammatory bowel diseases (IBDs), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic conditions characterized by immune dysregulation.
- The pathogenesis involves a complex interplay between a genetically predisposed host and luminal antigens, potentially microbial in origin.
- Recent advancements have significantly improved our understanding of IBD pathophysiology.
Purpose of the Study:
- To provide an update on key recent developments in IBD research.
- To emphasize the translational aspects of research findings relevant to patient care.
- To highlight the roles of specific genes, receptors, and cytokines in gut inflammation.
Main Methods:
- Review of recent scientific literature and research findings.
- Focus on genetic discoveries, such as the NOD2 gene.
- Examination of the roles of Toll-like receptors, dendritic cells, and proinflammatory cytokines.
Main Results:
- The discovery of the NOD2 gene provides evidence for host-microbe interactions in Crohn's disease.
- Toll-like receptors and dendritic cells are implicated in the development of gut inflammation.
- Proinflammatory cytokines play a crucial role in the potentiation of gut inflammation.
Conclusions:
- Understanding the genetic and molecular underpinnings of IBD is crucial for advancing patient care.
- Translational research connecting basic science discoveries to clinical applications is vital for improving IBD management.
- Continued investigation into the immune response in IBD holds promise for novel therapeutic strategies.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...